Mindfulness and CBT for Preventing Severe Mental Illness in Youth
(SWELL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to test a new approach called maCBT to prevent severe mental illnesses like schizophrenia or mood disorders in young people. MaCBT, which stands for Multimodal Antecedent-focused Cognitive-behavioral Training, targets early warning signs such as anxiety, unusual sensory experiences, and mood swings. The goal is to help young individuals manage these symptoms early, potentially preventing severe mental illness later in life. This trial may suit young people aged 9-21 who have experienced anxiety, mood swings, or other early signs of mental health issues but have not been diagnosed with a severe mental illness. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could transform early mental health interventions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this intervention is safe for young people?
Research shows that Mindfulness and Cognitive Behavioral Therapy (CBT) are generally safe and well-tolerated. Studies have found that CBT helps people change unhelpful behaviors, improving mental health. When combined with CBT, mindfulness practices effectively prevent depression recurrence and enhance overall mental well-being.
Mindfulness-based cognitive therapies have increased life satisfaction and improved family relationships in teens. These therapies help individuals become more aware of their thoughts and feelings in the present moment, leading to better coping strategies.
While every treatment can have side effects, mindfulness and CBT are known for having few, if any, serious negative effects. They are widely used and accepted in mental health treatment, making them a safe option for young people.12345Why are researchers excited about this trial?
Researchers are excited about maCBT because it offers a fresh approach to preventing severe mental illness in youth by integrating mindfulness with cognitive-behavioral techniques. Unlike traditional treatments that often focus on managing symptoms after they appear, maCBT aims to normalize unusual experiences and equip young people with proactive strategies to reduce their impact. This treatment is tailored to be age-appropriate, using visual materials and relatable language, making it particularly engaging for children and teens. Additionally, maCBT is delivered in a flexible format, with sessions that initially occur weekly and then shift to bi-weekly, allowing for personalized pacing and sustained support.
What evidence suggests that maCBT might be an effective treatment for preventing severe mental illness in youth?
Research has shown that Mindfulness and Acceptance-based Cognitive Behavioral Therapy (maCBT), which participants in this trial may receive, can help prevent serious mental health issues in young people. Studies have found that mindfulness-based therapy can improve life satisfaction and family relationships for teenagers. This therapy manages anxiety and unusual experiences by teaching self-management skills. maCBT helps young people understand and rethink unusual experiences, enabling them to develop coping strategies. These strategies aim to reduce the impact of early signs of mental health issues, such as anxiety and mood changes, before they worsen. Overall, maCBT appears promising in helping at-risk youth avoid severe mental health problems later in life.13678
Who Is on the Research Team?
Rudolf Uher, MD
Principal Investigator
Nova Scotia Health Authority
Are You a Good Fit for This Trial?
This trial is for young individuals aged 9-21 who are part of the FORBOW study, showing early signs that may predict severe mental illness, like anxiety or mood swings. It's not for those with a severe mental illness diagnosis or who've had significant therapy recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT) in 8 to 16 one-hour sessions, initially weekly, then bi-weekly.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 4-6 months, 1, 2, 3, and 5 years post intervention.
Long-term follow-up
Annual follow-ups to assess long-term outcomes such as severe mental illness diagnosis and functioning.
What Are the Treatments Tested in This Trial?
Interventions
- maCBT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor
Nova Scotia Health Research Foundation
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator